Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00117416

Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function

MAP and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the renal perfusion depending on the MAP.

Conditions

Interventions

TypeNameDescription
PROCEDUREcontrolling the MAP

Timeline

Start date
2003-02-01
Primary completion
2003-02-01
Completion
2003-02-01
First posted
2005-07-06
Last updated
2022-12-20

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00117416. Inclusion in this directory is not an endorsement.

Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduce (NCT00117416) · Clinical Trials Directory